Aug 31, 2020   SOURCE: PR NewsWire

ThermoGenesis Holdings to Participate in Investor Conferences in September

RANCHO CORDOVA, Calif., Aug. 31, 2020 /PRNewswire/ -- ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, today announced management's participation in the following investor conferences in September.

    --  September 1-4: LD Micro 500. Chris Xu, Ph.D., Chief Executive Officer of
        ThermoGenesis, will present a company overview at this virtual
        conference on Wednesday, September 2, at 5:00 pm ET. A live webcast of
        the presentation will be available on the ThermoGenesis website at:
        https://ThermoGenesis.com/investors/news-and-events/events-webcasts. An
        archived replay will be available for a period of 90 days after the
        conference.

    --  September 14-16: H.C. Wainwright 22(nd) Annual Global Investment
        Conference. Jeff Cauble, Chief Financial Officer of ThermoGenesis, will
        present a company overview at this virtual conference on Tuesday,
        September 15, at 12:00 pm ET. A live webcast of the presentation will be
        available on the ThermoGenesis website at:
        https://ThermoGenesis.com/investors/news-and-events/events-webcasts. An
        archive replay will be available for a period of 90 days after the
        conference.

About ThermoGenesis Holdings, Inc.
ThermoGenesis Holdings, Inc. develops, commercializes, and markets a range of automated technologies for CAR-T and other cell-based therapies. The Company currently markets a full suite of solutions for automated clinical biobanking, point-of-care applications, and automation for immuno-oncology, including its semi-automated, functionally-closed CAR-TXpress(TM) platform, which streamlines the manufacturing process for the emerging CAR-T immunotherapy market. For more information about ThermoGenesis, please visit: www.thermogenesis.com.

Company Contact:
Wendy Samford
916-858-5191
ir@ThermoGenesis.com

Investor Contact:
Paula Schwartz, Rx Communications
917-322-2216
pschwartz@rxir.com

View original content:http://www.prnewswire.com/news-releases/thermogenesis-holdings-to-participate-in-investor-conferences-in-september-301120615.html

SOURCE ThermoGenesis Holdings, Inc.